Back to ICCC

CITADEL ADVISORS LLC → ICCC

CITADEL ADVISORS LLC ICCC Position History

ImmuCell Corporation • Healthcare

Quarters held
13
Latest value
$296K
Q3 2026
Peak value
$407K
First seen
Q1 2023

Dollar value over time

Show data table
PeriodPosition value
Q1 2023$87K
Q2 2023$57K
Q3 2023$77K
Q2 2024$115K
Q4 2024$149K
Q1 2025$115K
Q2 2025$285K
Q3 2025$139K
Q4 2025$242K
Q1 2026$226K
Q2 2026$407K
Q2 2026$407K
Q3 2026$296K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$296K30.2K——
Q2 2026$407K40.5K——
Q2 2026$407K40.5K——
Q1 2026$226K35.7K——
Q4 2025$242K39.4K——
Q3 2025$139K21.5K——
Q2 2025$285K41.0K——
Q1 2025$115K23.9K——
Q4 2024$149K29.0K——
Q2 2024$115K23.7K——
Q3 2023$77K15.0K——
Q2 2023$57K11.2K——
Q1 2023$87K17.0K——

Other funds holding ICCC

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$11.2B
SPY

SPDR S&P 500 ETF TR

$3B
MSFT

MICROSOFT CORP

$2.9B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
SPY

STATE STR SPDR S&P 500 ETF T

$2.4B